Nuclear medicine market to be worth $5.5 billion by 2017

The nuclear medicine market has been forecast to increase at a compound annual growth rate (CAGR) of 7.8% over the next five years, rising from a valuation of $3.8 billion in 2012, to hit a market value of $5.5 billion by the year 2017. Continue reading